Abstract:A low‐toxic aggregate of manganese‐based polyoxometalate single‐atom enzyme (Mn‐POM SAE) is constructed at neutral conditions. Specifically, Mn‐POM SAE nanospheres exhibit acid‐triggered nontoxicity‐to‐toxicity transition in acid tumor microenvironment (TME), upon degradation of larger Mn‐POM SAE into smaller toxic units of Mn(II)‐PW11. Therefore, the multienzyme‐mimicking (POD‐, OXD‐, CAT‐, and Gpx‐like) activity is initiated through single/double electron transfers for efficient and specific therapy. Single‐atom enzymes (SAzymes) exhibit great potential for chemodynamic therapy (CDT); while, general application is still challenged by their instability and unavoidable side effects during delivery. Herein, a manganese‐based polyoxometalate single‐atom enzyme (Mn‐POM SAE) is first introduced into tumor‐specific CDT, which exhibits tumor microenvironment (TME)‐activated transition of nontoxicity‐to‐toxicity. Different from traditional POM materials, the aggregates of low‐toxic Mn‐POM SAE nanospheres are obtained at neutral conditions, facilitating efficient delivery and avoiding toxicity problems in normal tissues. Under acid TME conditions, these nanospheres are degraded into smaller units of toxic Mn(II)‐PW11; thus, initiating cancer cell‐specific therapy. The released active units of Mn(II)‐PW11 exhibit excellent multienzyme‐like activities (including peroxidase (POD)‐like, oxidase (OXD)‐like, catalase (CAT)‐like, and glutathione peroxidase (Gpx)‐like activities) for the synergistic cancer therapy due to the stabilized high valence Mn species (MnIII/MnIV). As demonstrated by both intracellular evaluations and in vivo experiments, ROS is generated to cause damage to lysosome membranes, further facilitating acidification and impaired autophagy to enhance cancer therapy. This study provides a detailed investigation on the acid‐triggered releasing of active units and the electron transfer in multienzyme‐mimic‐like therapy, further enlarging the application of POMs from catalytical engineering into cancer therapy.

Hetero-bimetallic Transition Metal-Substituted Krebs-type Polyoxometalate with N-chelating Ligand As Anticancer Agents

Two Metal–Organic Coordination Polymers Based on Polypyridyl Ligands: Crystal Structures and Inhibition of Human Spinal Tumour Cells

Discovery of a New Family of Polyoxometalate-Based Hybrids with Improved Catalytic Performances for Selective Sulfoxidation: the Synergy Between Classic Heptamolybdate Anions and Complex Cations.

Polyoxometalate-Based Organic-Inorganic Hybrids as Antitumor Drugs.

Tris‐functionalized polyoxotungstovanadate‐mediated antitumor efficacy involves multiple cell death pathways

Polyoxometalate-biomolecule Conjugates: a New Approach to Create Hybrid Drugs for Cancer Therapeutics.

Ni/Mn-Complex-Tethered Tetranuclear Polyoxovanadates: Crystal Structure and Inhibitory Activity on Human Hepatocellular Carcinoma (HepG-2)

Antitumor Effects of a Sb-rich Polyoxometalate on Non-Small-Cell Lung Cancer by Inducing Ferroptosis and Apoptosis

Controllable Assembly of Mo VI 36 -Based Polyoxometalate Porous Frameworks with Silver Ions and Lung Cancer Cell-Specific Cytotoxicity

Inhibitory effects of different substituted transition metal-based krebs-type sandwich structures on human hepatocellular carcinoma cells.

Multienzyme‐Like Polyoxometalate‐Based Single‐Atom Enzymes for Cancer‐Specific Therapy Through Acid‐Triggered Nontoxicity‐to‐Toxicity Transition

Transition Metal Substituted Sandwich-Type Polyoxometalates with a Strong Metal–c (imidazole) Bond As Anticancer Agents

Polyoxometalates Nanoparticles Improve Anti-Tumor Activity by Maximal Cellular Uptake

A Highly Biocompatible Polyoxotungstate with Fenton‐like Reaction Activity for Potent Chemodynamic Therapy of Tumors

Novel Antitumor Agent, Trilacunary Keggin-Type Tungstobismuthate, Inhibits Proliferation and Induces Apoptosis in Human Gastric Cancer Sgc-7901 Cells

An Unprecedented Class of Benzoyldiazenido‐Functionalized Polyoxometalates with Enhanced Antitumour Activities

The Synthesis and Biological Function of a Novel Sandwich-Type Complex Based on {SbW9 } and Flexible bpp Ligand

A Nanomedicine Based on Stoichiometric Coordination of Camptothecin and Organoplatinum (II) for Synergistic Antitumor Therapy.

Antitumor Activity of A Trans-Thiosemicarbazone Schiff Base Palladium (ii) Complex on Human Gastric Adenocarcinoma Cells

Enhanced antitumor activity of polyoxometalates loaded solid lipid nanoparticles

Cation-mediated optical resolution and anticancer activity of chiral polyoxometalates built from entirely achiral building blocks.